登录新浪财经APP 搜索【信披】查看更多考评等级 ■ 注：因增加、删除了部分条款，公司章程的条款编号相应变化。 除上述条款修订外，《公司章程》其他条款内容不变。上述事项尚需提请公司2024年年度股东大会审 议。股东大会审议通过后将修改《公司章程》，并授权董事会及其授权的其他人士办理工商变更登记相 关手续。以上事项最终修订结果以工商部门登记、备案结果为准。 三、制定、修订相关制度 为进一步规范公司运作，不断完善公司治理体系，保护投资者合法权益，公司根据《中华人民共和国公 司法》《上市公司章程指引》《上市公司治理准则》《中国证券监督管理委员会关于修改、废止部分证 券期货规范性文件的决定》等相关法律法规、规范性文件的最新规定和要求，公司拟制定相关制度，并 对部分制度进行相应地修订。 ■ 上述《中农立华生物科技股份有限公司独立董事工作细则》《中农立华生物科技股份有限公司董事会议 事规则》《中农立华生物科技股份有限公司对外担保管理制度》《中农立华生物科技股份有限公司募集 资金管理办法》《中农立华生物科技股份有限公司关联交易管理办法》《中农立华生物科技股份有限公 司重大投资决策管理办法》《中农立华生物科技股份有限公司利润 ...

Summary of Key Points Core Viewpoint - The company, Phoenix Shipping (Wuhan) Co., Ltd., has provided a guarantee for its wholly-owned subsidiary, Shanghai Huatai Shipping Co., Ltd., to secure a credit facility of 10 million yuan from Nanjing Bank, Shanghai Branch [2][4]. Group 1: Guarantee Overview - On March 6, 2025, the company's board approved a proposal to provide a guarantee for its subsidiary's credit application [2]. - The guarantee is a joint liability guarantee for a credit limit of 10 million yuan [2]. - The financing term is set for one year [2]. Group 2: Guarantee Details - The guarantee covers the principal debt, interest (including compound interest and penalties), damages, and other amounts payable under the main contract [2]. - The guarantee period extends for three years from the maturity of each debt incurred under the credit limit [3]. Group 3: Cumulative Guarantee and Financial Impact - As of April 8, 2025, the company has no other external guarantees and has not faced overdue debts or litigation related to guarantees [4]. - The total guarantee amount after this transaction is 10 million yuan, representing 1.84% of the company's audited net assets from the previous year [4].

Summary of Key Points Core Viewpoint - The company, BrightGene (Suzhou) Pharmaceutical Co., Ltd., plans to apply for a comprehensive credit limit of up to 3 billion RMB for the year 2025 from banks and financial leasing companies, with mutual guarantees among its subsidiaries [1][2]. Group 1: Credit Application and Guarantee - The total credit limit proposed for 2025 is not to exceed 3 billion RMB, which will include various types of loans and financial services [1][2]. - As of December 31, 2024, the total amount of guarantees provided by the company to its subsidiaries is 1,139.63 million RMB, accounting for 47.59% of the company's audited net assets and 22.07% of its total audited assets for the year 2024 [1][20]. - The proposed guarantees do not involve any counter-guarantees [1]. Group 2: Shareholder Meeting and Authorization - The proposal for the credit application and guarantees will be submitted for approval at the company's 2024 annual general meeting [2]. - The shareholders will authorize the legal representative or their delegate to negotiate specific credit business types, terms, rates, and to sign relevant contracts and agreements [2]. Group 3: Subsidiary Information - BrightGene (Suzhou) Pharmaceutical Co., Ltd. holds an 80% stake in BrightGene Pharmaceutical (Suzhou) Co., Ltd., which has total assets of 571.92 million RMB and net assets of 277.19 million RMB as of December 31, 2023 [2][3]. - The company also has several subsidiaries, including Suzhou Guangtai Biotechnology Co., Ltd. and BrightGene International (HK) Limited, with varying financial metrics and operational scopes [3][4][5]. Group 4: Financial Health and Performance - The financial performance of the subsidiaries shows a mix of revenues and losses, with some subsidiaries reporting zero revenue and negative net profits for 2023 and projected for 2024 [3][4][5][10][11]. - The overall financial health of the company and its subsidiaries indicates a need for the proposed credit to support ongoing operations and growth [1][20]. Group 5: Board and Regulatory Approval - The board of directors approved the proposal with a unanimous vote, indicating strong internal support for the credit application and guarantee strategy [20]. - The proposal complies with relevant regulations and has undergone necessary approval processes as per the Shanghai Stock Exchange rules [20].

Core Viewpoint - Jiangsu Lianrui New Materials Co., Ltd. plans to apply for a comprehensive credit limit of up to 760 million RMB from banks and provide guarantees for its wholly-owned subsidiary, Lianrui New Materials (Lianyungang) Co., Ltd. for up to 130 million RMB [1][2][6] Summary by Sections Credit and Guarantee Overview - The company intends to apply for a total credit limit not exceeding 760 million RMB for the year 2025, which includes various types of credit facilities such as loans, guarantees, and trade financing [1][2] - The total amount of guarantees provided by the company for its subsidiary is capped at 130 million RMB, with the current guarantee balance being 14,716,059.46 RMB [1][2][7] - The guarantee does not require counter-guarantees and does not need to be approved by the shareholders' meeting [1][2] Internal Decision-Making Process - The board of directors and the supervisory board approved the proposal for the credit application and guarantee during meetings held on March 24, 2025 [2][3] - The decision is valid until the next board or shareholders' meeting, allowing for the revolving use of the credit and guarantee limits within the authorized scope [2][6] Subsidiary Information - The guaranteed entity, Lianrui New Materials (Lianyungang) Co., Ltd., is a wholly-owned subsidiary of the company, established on July 22, 2020, with a registered capital of 350 million RMB [3][4] - The subsidiary's business scope includes manufacturing electronic materials, non-metallic mineral products, and various specialized materials [4] Financial Data of the Subsidiary - As of the latest audited financials, the subsidiary reported total assets of approximately 558.98 million RMB and total liabilities of about 107.32 million RMB, resulting in a net asset value of approximately 451.66 million RMB [5] - The subsidiary's revenue for the period was approximately 330.47 million RMB, with a net profit of about 57.02 million RMB [5] Reasons and Necessity for Guarantee - The guarantee is aimed at meeting the financing needs of the subsidiary, which has a strong operational and credit standing, indicating manageable risk [6][7] - The board and supervisory board believe that the guarantee aligns with the company's overall development strategy and will not harm the interests of the company or its shareholders [6][7] Cumulative External Guarantee Amount - As of the announcement date, the total external guarantee balance provided by the company and its subsidiaries is 14,716,059.46 RMB, representing 0.98% of the latest audited net assets and 0.75% of total assets [7]

兴通股份: 兴通海运股份有限公司关于2025年度公 司及所属子公司申请综合授信及提供担保的公告 证券代码：603209 证券简称：兴通股份 公告编号：2025-021 兴通海运股份有限公司 关于 2025 年度公司及所属子公司申请综合授信 ? 对外担保逾期的累计数量：无 ? 该事项尚需提交股东大会审议 会第二十一次会议，审议通过《兴通海运股份有限公司关于 2025 年度公司及所 属子公司申请综合授信及提供担保的议案》，并提请股东大会批准董事会授权公 司或子公司经营管理层根据实际经营情况的需要，在下述范围内办理银行、融资 租赁等机构授信及提供担保事宜，签署授信、担保协议、资产抵押等相关法律文 件。 一、授信及担保情况概述 及提供担保的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ? 被担保方名称：兴通海运股份有限公司（以下简称"公司"）合并报表 范围内子公司（包括授权期限内新设立、收购等方式取得的全资子公司、控股子 公司，以下简称"子公司"） ? 本次担保金额及已实际为其提供的担保余额：本次担保金额不超过 ...

证券代码：603366 证券简称：日出东方 公告编号：2025-006 日出东方控股股份有限公司 关于为全资子公司提供担保的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 一、担保情况概述 为满足公司及直接或间接控股的子公司（含子公司直接或间接控股的孙公 司）日常经营发展需要、拓宽融资渠道，公司分别于 2024 年 4 月 25 日、2024 年 5 月 22 日召开第五届董事会第十次会议和 2023 年年度股东大会，审议通过了 《关于公司及子公司 2024 年度向银行申请综合授信并对子公司提供担保的议 案》，同意为公司直接或间接控股的子公司（含子公司直接或间接控股的孙公司） 在 30 亿元综合授信额度内，提供不超过 25 亿元的担保。担保期限自公司股东大 会审议通过之日起至 2024 年度股东大会召开之日止。具体内容详见公司于 2024 年 4 月 26 日披露的《关于公司及子公司 2024 年度向银行申请综合授信并对子公 司提供担保的公告》（公告编号：2024-007)。 2025 年 2 ...